ATAI and LLY Related Headlines
Go Back- Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'
- Eli Lilly to acquire AtaiBeckley for up to $3.8B
- Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
- Lilly Said To Near Deal For Psychedelic Drugmaker Ataibeckley - Bloomberg

